The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

For active investors, the challenge is not typically finding a good stock or an entry point; it’s knowing where to get out. When a stock surges past its previous high, you enter what technical ...

After three years of unprecedented tech spending and nonstop hype, the demand for AI in the workplace seems to be drying up fast. Looking at the big picture doesn’t make it any prettier. Back in March ...

With the holidays are just around the corner, your savings might be taking a hit. Why not take a shot at one of the year's biggest Powerball jackpots? Saturday's prize has reached $1 billion and while ...

FAYETTEVILLE, Ark. (KNWA/KFTA) — It was officially announced Sunday that Arkansas had landed on Ryan Silverfield as its new head football coach. The hiring received mixed reactions from fans and ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Were you a lucky winner? Check your tickets for lottery draw games in West Virginia here. *Based on iOS download data collected by Sensor Tower. Jackpocket is the official digital lottery courier of ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...